Regulatory T-cell therapy calms autoimmune response from gluten-sensitive T cells in mice
For the 80 million people worldwide who have celiac disease, the only treatment available is to cut grains like pasta and bread out of their lives. But researchers are hoping to change that with a new cell therapy that, in mice, was able to tamp down the immune system’s overreaction to gluten.
For the 80 million people worldwide who have celiac disease, the only treatment available is to cut grains like pasta and bread out of their lives. But researchers are hoping to change that with a new cell therapy that, in mice, was able to tamp down the immune system’s overreaction to gluten.
